Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Vaccine

Monkeypox vaccine ‘in short supply’ as cases rise by two in Scotland

A VACCINE for monkeypox is “in short supply globally” as cases increased by two in Scotland since last week.

The National (Scotland)

Biotech Daily: Regulatory Setback For CorMedix, Mersana & GSK In Cancer Pact, BARDA Funding For Opioid Overdose Hopeful

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

Children under 10 will get polio boosters as virus returns to UK after 40 years

Youngsters to be offered shots from Wednesday

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

John Oliver slams Warner Bros for cancelling Batgirl: ‘Burning down my network’

‘We let the vaccine sit unused on a shelf in our reserves like an expired Chobani or a $90m movie on HBO Max,’ Oliver said

The Independent UK

Monkeypox fears build as number of cases in Greater Manchester rise ahead of Pride amid "stay home if ill" warning

'Manchester has been left behind when we could have been protected'

Manchester Evening News

Polio boosters for under-10s amid fears of spreading outbreak

The amount of poliovirus samples picked up suggests it has been passing from person to person.

Wales Online

Trial seeks to develop first Lyme disease vaccine in 2 decades

The only Lyme disease vaccine previously marketed in the U.S. was discontinued in 2002.

Axios

Read news from The Economist, FT, and more,
with one subscription

Recap of Monday's Biotech Catalysts - End Of the Day Summary

Kodiak Sciences Inc. (NASDAQ:KOD) announced positive topline results its BEACON Phase 3 study of tarcocimab tedromer (KSI-301; tarcocimab) in patients with macular edema due to retinal vein occlusion. Kodiak shares traded in a range of $10.02 to $11.79 on a day volume of 4.05 million shares, closed regular trading session…

Benzinga

Monkeypox immunity tests to begin

The Department of Medical Science is seeking volunteers who received the smallpox vaccine when it was still being widely administered prior to 1980 to test whether they have been left with any residual immunity against monkeypox having successfully cultivated test strains of the new virus in their laboratories.

Bangkok Post

Major test of first possible Lyme vaccine in 20 years begins

Researchers are seeking thousands of volunteers in the U.S. and Europe to test the first potential vaccine against Lyme disease in 20 years

The Independent UK

Monkeypox vaccines have arrived in Victoria. Here's how the rollout will work

The first 3,500 doses will be available to Victorians most at risk of contracting the virus, which has spread to more than 70 countries and infected about 26,000 people around the world.

ABC News

Polio booster to be given to under-10s to prevent first UK outbreak in 50 years

The UK Health Security Agency has repeatedly detected the poliovirus in London’s sewage works and is now calling on parents to make sure their children are fully vaccinated

Daily Mirror

Altruism – but also vulnerability – drive healthy volunteers to take part in clinical research

When UK authorities granted permission in October 2020 for the first controlled infection study to be carried out to test the anti-Covid-19 vaccine Oxford University had just developed, reactions ranged from disbelief to disapproval.

The Conversation

Scottish monkeypox cases rise to 67 as WHO experts declare global emergency

Monkeypox cases across the UK are on the rise. Amidst World Health Organisation concerns, Public Health Scotland's vaccine program is getting under way despite limited global supply.

Edinburgh Live

Get all your
news in one place.

100's of premium titles.
One news app.

Los Angeles Times

Sex pods? Long sleeves? Californians try to cut monkeypox risk while waiting for shots

LOS ANGELES — As Kelechi Kalu books gigs as a musician, he wonders whether he is putting himself at risk for monkeypox.

The Independent UK

BioNTech reports strong first half, expects demand to grow

BioNTech, which teamed with Pfizer to develop the first widely used COVID-19 vaccine, has reported higher revenue and net profit in the first half of the year

Reuters

Climate change puts Lyme disease in focus for France's Valneva after COVID blow

With climate change spurring more cases of tick-borne Lyme disease, drugmaker Valneva is betting big on a vaccine as it looks beyond disappointing sales of its COVID shot.

AAP

Vaccine side-effect milder than COVID-19

COVID-19 complications are more of an issue for adolescents and young adults than the rare side-effect of myocarditis from mRNA virus vaccines, experts say.

Get all your
news in one place.

100's of premium titles.
One news app.

Bangkok Post

The possible upsides to Covid infection

There's always a first time for everyone. After three years of living life virus free, I got Covid-19 from a friend after attending a concert recently. However, to my surprise, my first experience wasn't all that terrible. I felt mildly ill, with fever and body aches, but no sore throat…

ABC News

Going to the Ekka? Here are the best ways to avoid getting sick with COVID-19, monkeypox or the flu

Eager to hit Brisbane's Ekka show to enjoy a dagwood dog or a strawberry sundae without coming down with COVID-19, monkeypox or the flu? Here are five key things you can do to protect your health.

ABC News

Sydney news: Former NSW deputy premier John Barilaro to face US trade role inquiry

MORNING BRIEFING: Former deputy premier John Barilaro will today appear before the inquiry created to investigate his appointment as NSW's trade commissioner to the Americas.

ABC News

NSW's monkeypox vaccine rollout begins by targeting those most at-risk

The people most vulnerable to contracting monkeypox are in line to receive the first doses in NSW's vaccine program.

The Hindu

Lumpy skin disease: Over 66,000 doses of goat pox vaccine procured by Punjab

Punjab, Rajasthan, Uttarakhand, Gujarat and Andaman and Nicobar Islands have been hit by the outbreak of the disease.

The New Daily

COVID-19 and autoimmune rheumatic diseases: Vaccine insufficient protection against Omicron

A study has found mRNA vaccines don't create enough antibodies to protect against the Omicron COVID variant in people with autoimmune rheumatic diseases.

The Guardian - US

‘Like winning the lottery’: Americans struggle to get monkeypox vaccines

Amid increases in appointment availability, experts and patients are observing that the vaccination process privileges a select few

1 … 210 211 212 213

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

UK Health Security Agency

World Health Organisation

267 stories

Public Health Scotland

254 stories

BioNTech

203 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.